10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
| Revenue (Most Recent Fiscal Year) | $610.78M |
| Net Income (Most Recent Fiscal Year) | $-182.63M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.68 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.48 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -24.56% |
| Net Margin (Trailing 12 Months) | -25.14% |
| Return on Equity (Trailing 12 Months) | -23.22% |
| Return on Assets (Trailing 12 Months) | -18.02% |
| Current Ratio (Most Recent Fiscal Quarter) | 5.37 |
| Quick Ratio (Most Recent Fiscal Quarter) | 4.68 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 2.32 |
| Book Value per Share (Most Recent Fiscal Quarter) | $5.74 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.36 |
| Earnings per Share (Most Recent Fiscal Year) | $-1.52 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.30 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 123.13M |
| Free Float | 111.57M |
| Market Capitalization | $1.05B |
| Average Volume (Last 20 Days) | 3.60M |
| Beta (Past 60 Months) | 1.94 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 9.39% |
| Percentage Held By Institutions (Latest 13F Reports) | 84.68% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |